Charles N Bernstein
Overview
Explore the profile of Charles N Bernstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
603
Citations
20560
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McIver T, Bernstein C, Kornelsen J
J Can Assoc Gastroenterol
. 2025 Feb;
8(Suppl 2):S36-S43.
PMID: 39990517
Crohn's disease and ulcerative colitis are 2 subtypes of Inflammatory Bowel Disease (IBD). The chronic, alternating periods of relapsing, and remitting inflammation of the gastrointestinal tract that underlie these diseases...
2.
Anand R, George A, Rubin D, Spiegel B, Bernstein C
J Can Assoc Gastroenterol
. 2025 Feb;
8(Suppl 2):S15-S20.
PMID: 39990506
Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is characterized by symptoms such as fatigue, abdominal pain, and diarrhoea, which may persist even when inflammation is controlled. These...
3.
Tshikudi D, Bernstein C, Mishra S, Ghia J, Armstrong H
Nat Rev Gastroenterol Hepatol
. 2025 Feb;
PMID: 39962330
The incidence of inflammatory bowel disease (IBD) has risen in the past decades and has emerged as a global health issue. IBD is characterized by chronic inflammation of the gastrointestinal...
4.
Kornelsen J, McIver T, Marrie R, Patel R, Bernstein C
Inflamm Bowel Dis
. 2025 Jan;
PMID: 39887158
No abstract available.
5.
Bernstein C, Nugent Z, Panaccione R, Marshall D, Kaplan G, Dieleman L, et al.
J Clin Gastroenterol
. 2025 Jan;
PMID: 39853241
Background: We aimed to examine the relationship between disease symptoms and disease phenotype in a large Canadian cohort of persons with Crohn's disease (CD). Methods: Adults (n=1515) with CD from...
6.
OMahony J, Bernstein C, Marrie R
BMJ Open
. 2025 Jan;
15(1):e087133.
PMID: 39833007
Objective: Adverse childhood experiences (ACE) have inconsistently been implicated as risk factors for immune-mediated inflammatory diseases (IMID). We evaluated whether the association of ACE with disease differs between IMID and...
7.
Shaffer S, Chu J, Algarni A, Nugent Z, Schaeffer D, Bernstein C
J Clin Gastroenterol
. 2025 Jan;
PMID: 39761164
Goals: We sought to understand the clinical course and risk of dysplasia in persons with UC who achieve near or complete normalization of histology. Background: Histologic remission and normalization in...
8.
Hesampour F, Tshikudi D, Bernstein C, Ghia J
Bioelectron Med
. 2024 Dec;
10(1):29.
PMID: 39648211
Background: Current inflammatory bowel disease (IBD) treatments often fail to achieve lasting remission and have adverse effects. Vagus nerve stimulation (VNS) offers a promising therapy due to its anti-inflammatory effects....
9.
Levis B, Bhandari P, Neupane D, Fan S, Sun Y, He C, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2429630.
PMID: 39576645
Importance: Test accuracy studies often use small datasets to simultaneously select an optimal cutoff score that maximizes test accuracy and generate accuracy estimates. Objective: To evaluate the degree to which...
10.
Venner J, Bernstein C
Gastrointest Endosc Clin N Am
. 2024 Nov;
35(1):19-39.
PMID: 39510687
There are several available endoscopic scoring systems that are designed to assess disease activity in inflammatory bowel disease. The most widely known is the Mayo endoscopic subscore for ulcerative colitis....